Hib (Hib3) immunization coverage among 1-year-olds (%) in Serbia
Serbia: Hib (Hib3) immunization coverage among 1-year-olds (%) was 92.0% in 2025. ◆ Volatile
Hib (Hib3) immunization coverage among 1-year-olds (%) in Serbia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, hib (hib3) immunization coverage among 1-year-olds (%) in Serbia stood at 92.0%.
The figure is down 3.2% on the previous year and down 3.2% over ten years.
Over the whole period, hib (hib3) immunization coverage among 1-year-olds (%) in Serbia peaked at 98.0% in 2008 and was at its lowest, 0.0%, in 2000.
Serbia ranks 82nd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Hib (Hib3) immunization coverage among 1-year-olds (%) in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 42.0% | — |
| 2007 | 89.0% | +111.9% |
| 2008 | 98.0% | +10.1% |
| 2009 | 94.0% | -4.1% |
| 2010 | 91.0% | -3.2% |
| 2011 | 93.0% | +2.2% |
| 2012 | 90.0% | -3.2% |
| 2013 | 92.0% | +2.2% |
| 2014 | 94.0% | +2.2% |
| 2015 | 95.0% | +1.1% |
| 2016 | 92.0% | -3.2% |
| 2017 | 95.0% | +3.3% |
| 2018 | 97.0% | +2.1% |
| 2019 | 97.0% | +0.0% |
| 2020 | 92.0% | -5.2% |
| 2021 | 91.0% | -1.1% |
| 2022 | 92.0% | +1.1% |
| 2023 | 93.0% | +1.1% |
| 2024 | 95.0% | +2.2% |
| 2025 | 92.0% | -3.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.3% | 0.0% | 98.0% | 10 |
| 2010s | 93.6% | 90.0% | 97.0% | 10 |
| 2020s | 92.5% | 91.0% | 95.0% | 6 |
Countries ranked near Serbia
- 82 Finland 92.0% compare
- 82 United Kingdom 92.0% compare
- 82 Thailand 92.0% compare
- 82 United States 92.0% compare
- 82 Australia 92.0% compare
- 82 Bangladesh 92.0% compare
- 82 Colombia 92.0% compare
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Population ages 75-79, female, annual growth rate 9.43 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0277 units per person (2025)
- Population ages 75-79, male, annual growth rate 9.13 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0187 units per person (2025)
Frequently asked questions
- What is hib (hib3) immunization coverage among 1-year-olds (%) in Serbia?
- Hib (hib3) immunization coverage among 1-year-olds (%) in Serbia was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hib (hib3) immunization coverage among 1-year-olds (%) recorded in Serbia?
- The highest recorded value was 98.0% in 2008.
- What is the lowest hib (hib3) immunization coverage among 1-year-olds (%) recorded in Serbia?
- The lowest recorded value was 0.0% in 2000.
- How does Serbia rank for hib (hib3) immunization coverage among 1-year-olds (%)?
- Serbia ranks 82nd out of 194 countries with data for 2025.
- Is hib (hib3) immunization coverage among 1-year-olds (%) rising or falling in Serbia?
- Over the last ten years it is down 3.2%. The long-run trend across the full record is volatile.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hib (Hib3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).